Prognostic value of lead V1 ST elevation during acute inferior myocardial infarction

Circulation

Volumn 122, Issue 5, 2010, Pages 463-469

  Wong, Cheuk Kit ^a   Gao, Wanzhen ^b   Stewart, Ralph A ^c   French, John K ^d   Aylward, Philip E ^e   Benatar, Jocelyne ^b   White, Harvey D ^c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

^d LIVERPOOL HOSPITAL   (Australia)

^e FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

electrocardiography; fibrinolysis; mortality; myocardial infarction; ST segment elevation

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; HIRULOG; STREPTOKINASE;

AGED; ARTICLE; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYSIS; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANTERIOR WALL MYOCARDIAL INFARCTION; ANTICOAGULANTS; ASPIRIN; BUNDLE-BRANCH BLOCK; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAM PATTERN; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HIRUDINS; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECOMBINANT PROTEINS; RISK FACTORS; STREPTOKINASE;

EID: 77955414717     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.924068     Document Type: Article

References (27)

1. Muller JE, Maroko PR, Braunwald E. Evaluation of precordial electro-cardiographic mapping as a means of assessing changes in myocardial ischemic injury. Circulation. 1975;52:16-27.
2. Mehta SR, Eikelboom JW, Natarajan MK, Diaz R, Yi C, Gibbons RJ, Yusuf S. Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction. J Am Coll Cardiol. 2001;37:37-43.
3. Berger PB, Ryan TJ. Inferior myocardial infarction: high-risk subgroups. Circulation. 1990;81:401-411.
4. Wong CK, Freedman SB. Reperfusion in acute inferior myocardial infarction: could tailored therapy be based on precordial ST depression? Am Heart J. 1996;131:1240-1247.
5. Schroder R, Wegscheider K, Schroder K, Dissmann R, Meyer-Sabellek W. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens: a substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. J Am Coll Cardiol. 1995;26:1657-1664.
6. Anderson RD, White HD, Ohman EM, Wagner GS, Krucoff MW, Armstrong PW, Weaver WD, Gibler WB, Stebbins AL, Califf RM, Topol EJ. Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Am Heart J. 2002;144:81-88.
7. de Lemos JA, Antman EM, Giugliano RP, Morrow DA, McCabe CH, Cutler SS, Charlesworth A, Schroder R, Braunwald E, for the InTIME-II Investigators. Comparison of a 60-versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. Am J Cardiol. 2000;86:1235-1237.
8. Cura FA, Roffi M, Pasca N, Wolski KE, Lincoff AM, Topol EJ, Lauer MS. ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy). Am J Cardiol. 2004;94:859-863.
9. Schroder K, Wegscheider K, Zeymer U, Tebbe U, Schroder R. Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction. Lancet. 2001;358:1479-1486. (Pubitemid 33055698)
10. Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. Lancet. 2001;358:1855-1863.
11. Wong CK, Stewart RAH, Gao W, French JK, Raffel OC, White HD, for the Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators. Prognostic differences between different types of bundle branch block during the early phase of acute myocardial infarction: insights from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. Eur Heart J. 2006;27:21-28.
12. Wong CK, French JK, Aylward PE, Stewart RA, Gao W, Armstrong PW, Van de Werf FJ, Simes RJ, Raffel OC, Granger CB, Califf RM, White HD. Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes. J Am Coll Cardiol. 2005;46:29-38.
13. Wong CK, Gao W, Raffel OC, French JK, Stewart RA, White HD. Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2. Lancet. 2006;367:2061-2067.
14. Wong CK, Gao W, Stewart RA, Van Pelt N, French JK, Aylward PE, White HD. Risk stratification of patients with acute anterior myocardial infarction and right bundle-branch block: importance of QRS duration and early ST-segment resolution after fibrinolytic therapy. Circulation. 2006;114:783-789.
15. Wong CK, Gao W, Stewart RAH, French JK, Aylward PEG, White HD. Relationship of QRS duration at baseline and changes over 60 minutes after fibrinolysis to 30-day mortality with different locations of ST elevation myocardial infarction: results from the HERO-2 trial. Heart. 2009; 95:276-282.
16. Wong CK, Gao W, Stewart RAH, Benatar JR, French JK, Aylward PE, White HD. aVR ST elevation: an important but neglected sign in ST elevation acute myocardial infarction. Eur Heart J. May 31, 2010. doi: 10.1093/eurheartj/ehq161. Available at: http://eurheartj.oxfordjournals. org/content/early/2010/05/30/ eurheartj.ehq161.long. Accessed May 31, 2010.
17. Bueno H, Lopez-Palop R, Bermejo J, Lopez-Sendon JL, Delcan JL. In-hospital outcome of elderly patients with acute inferior myocardial infarction and right ventricular involvement. Circulation. 1997;96: 436-441.
18. Bueno H, Lopez-Palop R, Perez-David E, Garcia-Garcia J, Lopez-Sendon JL, Delcan JL. Combined effect of age and right ventricular involvement on acute inferior myocardial infarction prognosis. Circulation. 1998;98: 1714-1720.
19. Assali AR, Teplitsky I, Ben Dor I, Solodky A, Brosh D, Battler A, Fuchs S, Kornowski R. Prognostic importance of right ventricular infarction in an acute myocardial infarction cohort referred for contemporary percutaneous reperfusion therapy. Am Heart J. 2007;153:231-237.
20. Lopez-Sendon J, Coma-Canella I, Alcasena S, Seoane J, Gamallo C. Electrocardiographic findings in acute right ventricular infarction: sensitivity and specificity of electrocardiographic alterations in right precordial leads V4R, V3R, V1, V2, and V3. J Am Coll Cardiol. 1985;6:1273-1279.
21. Matetzky S, Freimark D, Chouraqui P, Rabinowitz B, Rath S, Kaplinsky E, Hod H. Significance of ST segment elevations in posterior chest leads (V7 to V9) in patients with acute inferior myocardial infarction: application for thrombolytic therapy. J Am Coll Cardiol. 1998;31:506-511.
22. Matetzky S, Freimark D, Feinberg MS, Novikov I, Rath S, Rabinowitz B, Kaplinsky E, Hod H. Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7-9: "hidden" ST-segment elevations revealing acute posterior infarction. J Am Coll Cardiol. 1999;34:748-753.
23. Agarwal JB, Khaw K, Aurignac F, LoCurto A. Importance of posterior chest leads in patients with suspected myocardial infarction, but nondi-agnostic, routine 12-lead electrocardiogram. Am J Cardiol. 1999;83: 323-326.
24. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction\executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). J Am Coll Cardiol. 2004;44:671-719.
25. Van de Werf F, Bax J, Betriu A, Blomstrand C, Crea F, Falk V, Filippatos G, Fox KAA, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt FWA, Weidinger FF, Weis M, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Aguirre FV, Al Attar N, Alegría E, Andreotti F, Benzer W, Breithardt O, Danchin N, Di Mario C, Dudek D, Gulba D, Halvorsen S, Kaufmann P, Kornowski R, Lip GYH, Rutten F. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29:2909-2945.
26. Ting HH, Krumholz HM, Bradley EH, Cone DC, Curtis JP, Drew BJ, Field JM, French WJ, Gibler WB, Goff DC, Jacobs AK, Nallamothu BK, O'Connor RE, Schuur JD. Implementation and integration of prehospital ECGs into systems of care for acute coronary syndrome: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, Emergency Cardiovascular Care Committee, Council on Cardiovascular Nursing, and Council on Clinical Cardiology. Circulation. 2008;118:1066-1079.
27. Wang K, Asinger RW, Marriott HJL. ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med. 2003;349:2128-2135.